According to the latest report by Renub Research, the global assisted reproductive technology (ART) market is poised to reach USD 49.30 billion by 2033, growing at a CAGR of 6.59% from 2025 to 2033. The market, valued at USD 27.76 billion in 2024, is being fueled by increasing infertility cases, rapid technological innovations in reproductive medicine, and a growing network of specialized fertility clinics worldwide.
📌 Read the full market report here: Assisted Reproductive Technology Market Size and Forecast 2025-2033
Market Overview
Assisted reproductive technology encompasses medical procedures that address infertility and improve the chances of conception. These include in-vitro fertilization (IVF), artificial insemination (AI), and other advanced methods.
Over the past decade, there has been a steady rise in infertility rates due to lifestyle factors, delayed pregnancies, hormonal disorders, and environmental influences. In response, governments, healthcare providers, and private fertility centers have invested heavily in state-of-the-art reproductive technology to meet the growing demand.
Request sample Report:https://www.renub.com/request-sample-page.php?gturl=assisted-reproductive-technology-market-p.php
Key Market Drivers
1. Rising Infertility Rates Globally
Infertility now affects approximately 15% of couples worldwide, with rates higher in urbanized regions. Delayed marriages, lifestyle stress, obesity, and environmental toxins have contributed significantly to the trend.
2. Technological Advancements in ART
Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, artificial intelligence-based embryo selection, and cryopreservation techniques are enhancing pregnancy success rates and reducing risks.
3. Supportive Government Policies
Several countries have introduced subsidies, insurance coverage, and tax benefits for fertility treatments, making ART procedures more affordable and accessible.
4. Growth of Specialized Fertility Clinics
The number of dedicated fertility centers is rapidly increasing, particularly in emerging economies, providing patients with advanced facilities and expert care.
Market Segmentation Insights
By Type
- In-Vitro Fertilization (IVF) – Dominates the market due to its higher success rates and technological integration.
- Artificial Insemination (AI) – Widely used for male infertility and less invasive treatment options.
- Others – Includes cryopreservation, ovulation induction, and gamete intrafallopian transfer.
By End User
- Hospitals – Equipped with advanced labs and multidisciplinary teams.
- Fertility Clinics – Offering specialized and personalized reproductive care.
- Other End Users – Includes research centers and standalone ART facilities.
Regional Analysis
1. North America
North America holds a significant share, led by the United States, due to high awareness, advanced healthcare infrastructure, and insurance coverage for ART.
2. Europe
Countries like the UK, Germany, and France have progressive policies for infertility treatments, leading to consistent demand growth.
3. Asia-Pacific
This region is witnessing the fastest growth due to medical tourism, cost-effective procedures, and rising infertility rates in countries like India, China, and Japan.
4. Latin America and Middle East
Increasing urbanization, changing lifestyles, and the emergence of modern fertility clinics are boosting adoption rates.
Competitive Landscape
Key players in the global assisted reproductive technology market are focusing on:
- Expanding service networks
- Investing in AI-driven embryo analysis
- Collaborating with genetic testing companies
- Offering financing options for patients
Prominent companies include:
- Vitrolife AB
- CooperSurgical, Inc.
- FUJIFILM Irvine Scientific, Inc.
- Merck KGaA
- Ferring Pharmaceuticals
- Genea Limited
- IVFtech ApS
New Publish Report:
https://www.openpr.com/news/4135483/pork-meat-market-projected-to-reach-usd-365-36-billion-by-2033
Future Outlook
With infertility rates expected to climb further and awareness campaigns making ART more acceptable socially, the market is set to experience strong and sustained growth. Emerging technologies like robot-assisted micromanipulation and stem-cell-based gamete development could redefine fertility treatments over the next decade.
10 Frequently Asked Questions (FAQs)
Q1: What is the projected size of the global assisted reproductive technology market by 2033?
A1: It is expected to reach USD 49.30 billion by 2033.
Q2: What is the current size of the ART market?
A2: As of 2024, the market is valued at USD 27.76 billion.
Q3: What is the CAGR for 2025–2033?
A3: The market is projected to grow at a CAGR of 6.59%.
Q4: Which ART method dominates the market?
A4: In-Vitro Fertilization (IVF) holds the largest share due to higher success rates.
Q5: Which region is growing the fastest in the ART market?
A5: The Asia-Pacific region is experiencing the highest growth rate.
Q6: What are the major factors driving the ART market?
A6: Rising infertility rates, technological advancements, supportive policies, and more fertility clinics.
Q7: Is ART covered by insurance?
A7: In many countries, ART procedures receive partial or full insurance coverage, depending on local policies.
Q8: How is technology improving ART success rates?
A8: Through innovations like AI-based embryo selection, genetic testing, and time-lapse imaging.
Q9: Which companies are leading in the ART industry?
A9: Vitrolife AB, CooperSurgical, FUJIFILM Irvine Scientific, Merck KGaA, and Ferring Pharmaceuticals are among the leaders.
Q10: What future innovations are expected in ART?
A10: Emerging technologies include robot-assisted micromanipulation and stem-cell-derived gametes.
About Renub Research
Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions.
We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.
Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.
Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com
